IPO research for individual investors

Find companies going public, track recent IPOs, and research before you invest

Search by company name, browse recent S-1 and F-1 filings, or look up a ticker symbol. Run an IPO Analysis to get a full research report before the company goes public.

IPO Companies (8)

Showing All Filings · Past Week filings

NuvOx Therapeutics, Inc.Ticker pending
Pre-IPO
FILEDJul 16, 2026
FORM TYPES-1
DAYS IN PIPELINE2 days
INDUSTRYPharmaceutical Preparations
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 1966126
Latigo Biotherapeutics, Inc.Ticker pending
Pre-IPO
FILEDJul 16, 2026
FORM TYPES-1
DAYS IN PIPELINE2 days
INDUSTRYPharmaceutical Preparations
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 2056611
BlossomHill Therapeutics, Inc.Ticker pending
Pre-IPO
FILEDJul 16, 2026
FORM TYPES-1
DAYS IN PIPELINE2 days
INDUSTRYPharmaceutical Preparations
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 1839970
Vogenx, Inc.Ticker pending
Pre-IPO
FILEDJul 14, 2026
FORM TYPES-1
DAYS IN PIPELINE4 days
INDUSTRYPharmaceutical Preparations
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 1903784
Churchill Capital Corp XIIITicker pending
Pre-IPO
FILEDJul 14, 2026
FORM TYPES-1
DAYS IN PIPELINE4 days
INDUSTRY
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: E9CIK: 2114229
Braveheart Bio, Inc.Ticker pending
Pre-IPO
FILEDJul 14, 2026
FORM TYPES-1
DAYS IN PIPELINE4 days
INDUSTRYPharmaceutical Preparations
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 2131524
Attovia Therapeutics, Inc.Ticker pending
Pre-IPO
FILEDJul 13, 2026
FORM TYPES-1
DAYS IN PIPELINE5 days
INDUSTRYBiological Products, (No Diagn…
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: DECIK: 2058707
YPF Energia Electrica S.A.Ticker pendingForeign Issuer
Pre-IPO
FILEDJul 12, 2026
FORM TYPEF-1
DAYS IN PIPELINE6 days
INDUSTRY
EXCHANGENot yet assigned
AMENDMENTS0 amendments
Incorporated: C1CIK: 2133716

Ready to invest in the next big IPO?

Create an account to run a full IPO Analysis — a professional-grade research report covering financials, leadership, risk factors, and market positioning before a company goes public.